October 15, 2008 (Chicago, IL) — Continuous amiodarone therapy after cardioversion of chronic atrial fibrillation (AF) is more effective at maintaining sinus rhythm and yields better clinical outcomes ...
September 14, 2009 (Durham, North Carolina) — Patients taking dronedarone (Multaq, Sanofi-Aventis) for prevention of recurrent atrial fibrillation (AF) are about half as likely to remain in sinus ...